Hong Zhang | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Hong Zhang
University of Texas Southwestern Medical Center, United States
Hong Zhang
Affiliation University of Texas Southwestern Medical Center
Country United States
Scopus ID 57192482890
Documents 28
Citations 550
h-index 13
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0003-3056-0343

Hong Zhang, is an orthopedic surgeon, biomedical innovator, and musculoskeletal research specialist affiliated with the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children in Dallas, Texas. His research activities focus primarily on pediatric spinal deformities, growth modulation, spinal instrumentation development, scoliosis correction technologies, and minimally invasive spinal surgery. Through a combination of clinical orthopedic expertise and translational biomedical engineering, Zhang has contributed to the development of novel surgical systems and patented technologies intended to improve the treatment of severe spinal deformities and early-onset scoliosis.[1]

As Director of the Division of Creative Innovations within the Seay Center for Musculoskeletal Research, Zhang has overseen multidisciplinary investigations involving experimental spine biomechanics, orthopedic implant design, pediatric spine growth modulation, and surgical correction strategies. His publication record, citation metrics, and patent portfolio demonstrate sustained scholarly engagement in orthopedic research and spinal deformity innovation.[2]

Abstract

Hong Zhang is recognized for contributions to orthopedic surgery research, spinal deformity correction technologies, and pediatric musculoskeletal innovation. His work has focused on improving surgical outcomes for severe scoliosis and kyphosis through biomechanical research, implant design, and translational clinical investigations. Zhang has also contributed to orthopedic device development through multiple United States patents related to spinal correction systems and stabilization technologies.[3] His scholarly publications in journals such as Spine Deformity, European Spine Journal, and Seminars in Spine Surgery highlight continued engagement in experimental spine research and orthopedic innovation.[4]

Keywords

Orthopedic Surgery, Pediatric Scoliosis, Spinal Deformity, Spine Research, Musculoskeletal Innovation, Early-Onset Scoliosis, Orthopedic Instrumentation, Growth Modulation, Biomedical Engineering, Pediatric Orthopedics

Introduction

The field of pediatric spinal deformity research requires coordinated advances in biomechanics, surgical techniques, implant engineering, and long-term clinical evaluation. Hong Zhang has contributed to this interdisciplinary area through research addressing early-onset scoliosis, thoracic deformities, vertebral correction systems, and growth-preserving spinal interventions. His investigations combine experimental orthopedic science with clinically applicable instrumentation design.[5]

Zhang obtained his medical degree from Tianjin Medical University in China and completed orthopedic surgery training at Tianjin Hospital before undertaking international orthopedic research and clinical scholarship programs in Italy and the United States. Since joining the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children, he has participated in numerous collaborative orthopedic research initiatives focused on pediatric spine disorders and surgical innovation.[6]

Research Profile

Hong Zhang currently serves as Director of the Division of Creative Innovations within the Center of Excellence in Spine Research at the Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, Texas. He also holds the academic position of Associate Professor in the Department of Orthopaedic Surgery at the University of Texas Southwestern Medical Center.[1]

His research profile demonstrates sustained focus on pediatric spinal deformities, including early-onset scoliosis, thoracic kyphosis, spinal growth modulation systems, minimally invasive thoracoscopic procedures, and spinal instrumentation biomechanics. Zhang’s work frequently integrates engineering methodologies, experimental spine models, and translational orthopedic device development.[7]

  • Early-onset scoliosis and pediatric spine growth research
  • Orthopedic implant and spinal instrumentation development
  • Growth modulation systems for spinal correction
  • Biomechanical evaluation of spinal deformity devices
  • Experimental and translational musculoskeletal research
  • Minimally invasive spinal surgical technologies

Research Contributions

Zhang has contributed extensively to the development of innovative spinal correction systems intended for severe spinal deformities and pediatric scoliosis treatment. His patented orthopedic technologies include spinal rod reduction devices, pedicle screw systems, stabilization fasteners, and hinge-link spinal correction devices designed to improve alignment control and surgical correction efficiency.[8]

A significant component of his recent research involves the development of growth modulation systems using dynamic spinal correction approaches. Experimental investigations involving porcine models and three-dimensional simulation technologies have supported the evaluation of biomechanical effectiveness and safety profiles of novel correction systems.[9]

Zhang’s work on vertebral column resection systems and angular kyphosis reduction devices has also contributed to understanding correction strategies for severe thoracic spinal deformities. These studies have explored both implant mechanics and surgical feasibility in complex deformity correction procedures.[10]

  • Development of hinge-link spinal correction technologies
  • Novel uniplanar correction systems for angular kyphosis
  • Dynamic scoliosis correction and growth modulation research
  • Biomechanical studies of pediatric spinal instrumentation
  • Experimental orthopedic implant design and testing

Publications

Hong Zhang has authored and co-authored multiple peer-reviewed scientific publications addressing pediatric scoliosis, thoracic deformity correction, spine biomechanics, and orthopedic surgical technologies.[11]

  1. Zhang H, Lima JM, Jo CH, and Sucato DJ. The closing triradiate cartilage stage identifies accelerated curve progression in idiopathic scoliosis. Spine Deformity (2026).
  2. Zhang H, Ross D, and Sucato DJ. Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis. European Journal of Orthopaedic Surgery & Traumatology (2026).
  3. Zhang H, Ross D, and Sucato DJ. A new uniplanar correction strategy for severe thoracic kyphosis: concept, device design, and simulation with a 3D-printed model. Spine Deformity (2026).
  4. Zhang H, Niese B, and Sucato DJ. Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system: a porcine model study. Spine Deformity (2026).
  5. Brooks JT, Carron CJ, Zhang H, and Sucato DJ. Going anterior for the surgical management of pediatric scoliosis: Indications and technique pearls. Seminars in Spine Surgery (2025).

Research Impact

According to available Scopus metrics, Zhang has produced 28 indexed scholarly documents with approximately 550 citations and an h-index of 13, reflecting measurable academic influence within orthopedic surgery and musculoskeletal research communities.[1] His research output has contributed to the scientific understanding of pediatric spinal deformities, spinal growth dynamics, and orthopedic implant biomechanics.

His work has also received recognition through national and international awards, including the John H. Moe Award for Best Basic Science presented by the Scoliosis Research Society in both 2009 and 2010.[12] Additional grant support from organizations such as the Pediatric Orthopedic Society of North America and the Scoliosis Research Society further reflects the relevance of his investigations within pediatric orthopedic research.

Award Suitability

Hong Zhang’s academic profile aligns with the objectives of the Innovative Research Award due to his sustained contributions to orthopedic surgery innovation, spinal deformity correction technologies, and translational pediatric spine research. His work demonstrates interdisciplinary integration between clinical orthopedic practice, biomechanical engineering, and experimental medical device development.[8]

The combination of peer-reviewed publications, patented surgical systems, funded research projects, and international scientific recognition supports consideration of Zhang’s contributions within the field of medicine and health sciences. His focus on improving treatment strategies for complex pediatric spinal conditions reflects ongoing commitment to clinically relevant biomedical innovation.[10]

Conclusion

Hong Zhang has established a scholarly and clinical research profile centered on pediatric orthopedic innovation and spinal deformity correction. Through collaborative orthopedic research, patented instrumentation systems, and translational experimental studies, he has contributed to the advancement of spinal surgery technologies and pediatric musculoskeletal care. His publication history, research awards, and scientific contributions collectively support recognition within international academic and biomedical innovation platforms.[11]

References

  1. Elsevier. (n.d.). Scopus author details: Hong Zhang, Author ID 57192482890. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57192482890
  2. University of Texas Southwestern Medical Center. (n.d.). Faculty and research profile information for Hong Zhang.
  3. United States Patent and Trademark Office. (2010). Method for the Correction of Spinal Deformities Using Rod-Plate Anterior System.
  4. Springer Nature. (2026). Spine Deformity journal publications authored by Hong Zhang.
  5. Zhang H, Ross D, and Sucato DJ. (2026). Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis.
    https://doi.org/10.1007/s00590-026-04778-y
  6. Texas Scottish Rite Hospital for Children. (n.d.). Seay Center for Musculoskeletal Research profile.
  7. Zhang H, Niese B, and Sucato DJ. (2026). Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system.
    https://doi.org/10.1007/s43390-026-01284-3
  8. United States Patent and Trademark Office. (2023). Hinge-Link Spinal Correction Device and Method.
  9. Wang XB, Zhang H, and Sucato DJ. (2023). Unilateral thoracic spinal nerve resection creates early onset thoracic scoliosis in an immature porcine model.
    https://doi.org/10.1007/s00586-023-07804-3
  10. Zhang H, Ross D, and Sucato DJ. (2024). A Novel Uniplanar Clamp-Hinge Correction System for Vertebral Column Resection of Severe Angular Kyphosis.
    https://doi.org/10.1007/s43390-023-00770-2
  11. Elsevier. (n.d.). Publication and citation metrics for Hong Zhang in orthopedic research.
  12. Scoliosis Research Society. (2010). John H. Moe Award for Best Basic Science.

Anna Sójka-Makowska | Medicine and Health Sciences | Forensic Scientist of the Year Award

Forensic Scientist of the Year Award

Anna Sójka-Makowska
Poznan University of Medical Sciences, Poznan, Poland
Anna Sójka-Makowska
Affiliation Poznan University of Medical Sciences
Country Poland
Scopus ID 57196022239
Documents 5
Citations 165
h-index 5
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-0193-0491

Anna Sójka-Makowska is associated with the Poznan University of Medical Sciences in Poland and has contributed to interdisciplinary clinical research involving temporomandibular disorders, neurophysiological diagnostics, dentistry, and related biomedical sciences. Her scholarly activities include investigations into temporomandibular dysfunctions, headache disorders, neuroendocrine biomarkers, and patient-centered therapeutic methodologies within modern dental and medical practice.[1] Her publication profile reflects continued academic engagement in diagnostic sciences and clinical assessment methodologies relevant to forensic and health-related research domains.[2]

Abstract

The professional activities of Anna Sójka-Makowska demonstrate sustained involvement in clinical and diagnostic investigations within dentistry and biomedical sciences. Her work has addressed temporomandibular disorders, neurophysiological examinations, headache-associated dysfunctions, and biomarker-oriented clinical studies. Through peer-reviewed publications and collaborative research projects, she has contributed to evidence-based methodologies that support patient diagnostics and interdisciplinary healthcare research.[3] The combination of clinical relevance and analytical rigor supports recognition within the framework of the Forensic Scientist of the Year Award.

Keywords

Temporomandibular Disorders, Dentistry, Neurophysiology, Biomarkers, Clinical Diagnostics, Prosthodontics, Oral Health Research, Forensic Medicine, Medical Sciences, Temporomandibular Joint Disorders.

Introduction

Research involving temporomandibular disorders and associated neurological or psychological conditions represents an important area within contemporary clinical medicine. Anna Sójka-Makowska has participated in studies examining the relationship between temporomandibular dysfunctions, headache disorders, stress-related conditions, and neuroendocrine biomarkers.[4] Her investigations have contributed to the understanding of diagnostic frameworks such as DC/TMD and related clinical assessment methodologies applied in patient-centered healthcare environments.[5]

The interdisciplinary nature of her research reflects collaboration across dentistry, neurology, behavioral sciences, and rehabilitation-oriented medicine. Such integration of clinical knowledge and analytical approaches aligns with the objectives of academic recognition programs focused on healthcare innovation and applied scientific contributions.

Research Profile

Anna Sójka-Makowska serves within the academic and clinical environment of Poznan University of Medical Sciences. Her research profile includes publications in journals related to craniofacial medicine, behavioral sciences, prosthodontics, and neurophysiology. She has participated in investigations concerning temporomandibular disorders among adolescents and adults, clinical examination protocols, patient satisfaction in prosthodontic treatment, and biomarker studies associated with neurological conditions.[6]

According to indexed academic records, her Scopus profile reports measurable citation activity and scholarly visibility within medical and dental sciences.[1] Her work demonstrates consistent involvement in clinically applicable research supported by peer-reviewed dissemination and interdisciplinary cooperation.

Research Contributions

A significant component of Anna Sójka-Makowska’s contributions involves the study of temporomandibular disorders and their relationship with neurological, psychological, and physiological indicators. Her studies have explored stress manifestations, anxiety, and psychosocial influences associated with temporomandibular dysfunctions in clinical populations.[7]

Recent investigations have focused on biomarkers including Nesfatin-1 and Ghrelin/GOAT in adolescent headache and epilepsy-related studies. These projects contribute to ongoing scientific discussions concerning neuroendocrine regulation, pain mechanisms, and diagnostic biomarkers relevant to neurological and craniofacial disorders.[8]

  • Clinical investigations into temporomandibular disorders and patient diagnostics.
  • Research on neuroendocrine biomarkers associated with headache and epilepsy conditions.
  • Comparative studies involving DC/TMD and RDC/TMD diagnostic methodologies.
  • Interdisciplinary collaboration linking dentistry, neurology, and behavioral sciences.
  • Peer-reviewed dissemination in clinical and biomedical journals.

Publications

Selected scholarly publications associated with Anna Sójka-Makowska include peer-reviewed articles, literature reviews, conference papers, and clinical studies relevant to dentistry and medical sciences.[9]

  • Is there a relationship between psychological factors and TMD? — Brain and Behavior (2019). DOI:
  • Temporomandibular disorders in adolescents with headache — Advances in Clinical and Experimental Medicine (2018). DOI:
  • Relations between the results of complex clinical and neurophysiological examinations in patients with temporomandibular disorders symptoms — CRANIO (2017). DOI:
  • Comparison of Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and RDC/TMD — IRONS Journal (2016).
  • Nesfatin-1 and Ghrelin/GOAT as Potential Biomarkers in Adolescent Headache with Temporomandibular Disorders — Journal of Medical Science (2025).

Research Impact

The academic impact of Anna Sójka-Makowska’s work is reflected through citation activity, collaborative publications, and participation in clinically oriented biomedical research. Her studies have addressed practical diagnostic challenges within dentistry and craniofacial medicine while also contributing to broader discussions involving pain disorders, neurophysiology, and behavioral health.[10]

Research concerning temporomandibular disorders and neuroendocrine biomarkers carries importance for both diagnostic sciences and patient management frameworks. The integration of clinical examinations with evidence-based analysis supports scientific advancement within healthcare disciplines and contributes to ongoing improvements in interdisciplinary diagnostic methodologies.

Award Suitability

Anna Sójka-Makowska demonstrates professional and academic characteristics relevant to the objectives of the Forensic Scientist of the Year Award. Her involvement in diagnostic research, clinical methodologies, and biomarker-based investigations illustrates a commitment to scientific rigor and interdisciplinary healthcare research.[11]

The combination of indexed publications, citation visibility, collaborative investigations, and contributions to patient-oriented diagnostics supports consideration for scholarly recognition. Her research profile reflects continued engagement with scientifically relevant issues that intersect clinical medicine, dentistry, neurophysiology, and evidence-based diagnostic practice.

Conclusion

Anna Sójka-Makowska has established a research portfolio centered on temporomandibular disorders, clinical diagnostics, neurophysiological assessment, and interdisciplinary medical investigations. Her scholarly contributions within dentistry and health sciences demonstrate consistency in research activity and participation in clinically applicable scientific studies.[12] Through publications, collaborative projects, and analytical clinical research, she represents a suitable candidate for recognition within international scientific award frameworks.

References

  1. Elsevier. (n.d.). Scopus author details: Anna Sójka-Makowska, Author ID 57196022239. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57196022239
  2. ORCID. (n.d.). Anna Sójka-Makowska ORCID Profile.
    https://orcid.org/0000-0002-0193-0491
  3. Sójka, A., et al. (2017). Relations between the results of complex clinical and neurophysiological examinations in patients with temporomandibular disorders symptoms. CRANIO.
    https://www.tandfonline.com/doi/full/10.1080/08869634.2017.1290907
  4. Sójka, A., et al. (2018). Temporomandibular disorders in adolescents with headache. Advances in Clinical and Experimental Medicine.
    https://www.researchgate.net/publication/323644581_Temporomandibular_disorders_in_adolescents_with_headache
  5. Sójka, A., Pilarski, J., & Hędzelek, W. (2021). Description of the methodology for clinical examination of patients with temporomandibular disorders according to DC/TMD classification. Dental Forum.
  6. ResearchGate. (n.d.). Anna Sójka publication and research overview.
  7. Sójka, A., et al. (2019). Is there a relationship between psychological factors and TMD? Brain and Behavior.
  8. Sójka, A., et al. (2025). Nesfatin-1 and Ghrelin/GOAT as Potential Biomarkers in Adolescent Headache with Temporomandibular Disorders. Journal of Medical Science.
  9. Sójka, A., et al. (2016). Comparison of Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and RDC/TMD in Evaluation of Temporomandibular Disorders. IRONS Journal.
  10. Poznan University of Medical Sciences. (n.d.). Department and Clinic of Prosthodontics research activities.
  11. International Forensic Scientist Awards. (n.d.). Award recognition and academic excellence framework.
  12. Sójka, A., et al. (2026). Comparison of the effectiveness of psycho-behavioral-relaxation and occlusal splint therapy in the treatment of myalgia. Dental and Medical Problems.

Odayme Quesada | Medicine and Health Sciences | Research Excellence Award

Assoc. Prof. Dr. Odayme Quesada | Medicine and Health Sciences | Research Excellence Award

University of Cincinnati, The Christ Hospital | United States

Assoc. Prof. Dr. Odayme Quesada is a clinician-scientist specializing in women’s cardiovascular health, with a strong focus on coronary microvascular and vasomotor dysfunction (CMVD), ANOCA, and MINOCA. Her research integrates innovative diagnostic strategies and targeted therapeutic approaches to improve cardiovascular outcomes in women. She has authored 78 Scopus-indexed publications, achieving 1,615 citations and an h-index of 22. Her scholarly contributions include high-impact journal articles, book chapters, and leadership in multicenter clinical trials. She has advanced specialized research programs and contributed significantly to understanding sex-specific cardiovascular risk factors and disease mechanisms.

                            Citation Metrics (Scopus)

2400

2000

1600

1200

800

400

0

 

Citations
1615
Documents
78
h-index
22

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award

Assist. Prof. Dr. Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award

Ordu University | Turkey

Dr. Fulya Erendor Cihan is an emerging researcher in gene and cell therapy, with a strong focus on precision gene editing, viral vector systems, and therapeutic strategies for metabolic and neurodegenerative diseases. Her work integrates advanced molecular biology techniques with translational research, particularly in diabetes, COVID-19 vaccine development, and neuroprotection. She has contributed to multiple nationally funded research projects and international collaborations, emphasizing lentiviral and adenoviral vector-based therapies. Her research outputs include high-impact journal publications, conference proceedings, and book chapters, reflecting her growing influence in biomedical innovation and experimental therapeutics.

                        Citation Metrics (Google Scholar)

300

250

200

150

100

50

0

 

Citations
150
Documents
25
h-index
5

Citations

Documents

h-index

View Google Scholar Profile  View ORCID Profile

Featured Publications


Gene and cell therapy of human genetic diseases: Recent advances and future directions

– Journal of Cellular and Molecular Medicine, 2024 | Cited by: 33

Xuefei Wang | Medicine and Health Sciences | Research Excellence Award

Prof. Xuefei Wang | Medicine and Health Sciences | Research Excellence Award

Zhongshan Hospital, Fudan University | China

Prof. Xuefei Wang is a leading researcher in gastric cancer biology and translational oncology, with over 100 peer-reviewed publications and significant citation impact. His work focuses on molecular mechanisms of tumor metastasis, DNA damage repair, and chemoradiotherapy resistance. He has contributed to high-impact journals such as Cell Death & Differentiation and Advanced Science. His research integrates CRISPR-based functional genomics, post-translational modifications, and targeted therapeutic development. He is actively involved in multi-institutional collaborations and serves as a reviewer for international SCI journals. His innovations include peptide-based therapeutic strategies targeting cancer resistance pathways.

View ORCID Profile  View ResearchGate Profile

Featured Publications

Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

Ms. Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

University of Wollongong | Australia

Ms. Ebeney Whillas is a sports nutrition researcher whose work focuses on nutrition-related experiences during the transition from elite sport to post-competitive life. Her research is grounded in qualitative inquiry, addressing a critical gap in sports nutrition literature by centering the voices of former elite athletes. She is the lead author of a peer-reviewed article published in Nutrients (MDPI), which examines how entrenched sporting cultures continue to shape eating behaviours, health perceptions, and wellbeing after retirement from elite competition. Her scholarship contributes to a growing recognition that athlete nutrition support must extend beyond performance-focused phases to encompass long-term health and adjustment. Ms. Whillas’ research interests include athlete transition, sports nutrition culture, and the relationship between nutrition practices and mental wellbeing. Through her work, she provides evidence to inform more holistic, sustainable, and athlete-centered nutrition interventions across the full athletic lifespan.

Profiles: Sci Profiles | LinkedIn

Featured Publications

• Whillas, E. K., Craddock, J. C., & Lambert, K. (2025). Navigating nutrition beyond elite sport: A qualitative exploration of experiences after retirement. Nutrients, 17(24), Article 3920. https://doi.org/10.3390/nu17243920

Fatma Magdi | Nursing and Health Professions | Best Researcher Award

Assist. Prof. Dr. Fatma Magdi | Nursing and Health Professions | Best Researcher Award

RAK Medical and Health Sciences University | United Arab Emirates

Dr. Fatma Magdi is an accomplished nursing researcher and academic at Ras Al Khaimah Medical and Health Sciences University (RAKMHSU), United Arab Emirates. Her scholarly work spans geriatric health, community nursing, mental health, and nursing education innovation, with additional interdisciplinary collaborations in bio-nanotechnology, AI in medical imaging, and biosensor technologies. She has authored and co-authored 25 Scopus-indexed publications, accumulating 95 citations across 94 documents, and holds an h-index of 7 (Scopus ID: 57225999851 | ORCID: 0000-0002-2762-3350). Her research has appeared in several high-impact international journals including Cell Biochemistry and Function, Heliyon, Nursing Open, Biological Research for Nursing, Palliative & Supportive Care, and Microchemical Journal. Dr. Fatma Magdi’s work emphasizes evidence-based nursing interventions to enhance the quality of life, sleep, and psychological well-being among elderly populations. She has developed innovative approaches such as home-based Tai Chi exercise programs and tele-nursing applications to promote holistic elder care. Her studies on COVID-19-related mental health, vaccine acceptance, and health behavior models have contributed valuable insights to public health and nursing practice. Beyond clinical and community research, Dr. Fatma Magdi multidisciplinary collaborations address artificial intelligence in healthcare, probiotic applications, and affordability of essential medications in developing nations. She has also contributed book chapters and review papers on the digital transformation of nursing and the future of healthcare education.

Profiles: Scopus | Google Scholar | ORCID | LinkedIn

Featured Publications

  1. Ibrahim, F. M., Fadila, D. E., & Elmawla, D. A. E. A. (2023). Older adults’ acceptance of the COVID‐19 vaccine: Application of the health belief model. Nursing Open, 10(10), 6989–7002. https://doi.org/10.1002/nop2.2084

  2. Ibrahim, F. M., Dabou, E. A. R., AbdelSamad, S., & Abuijlan, I. A. M. (2024). Prevalence of bullying and its impact on self-esteem, anxiety and depression among medical and health sciences university students in Ras Al Khaimah, UAE. Heliyon, 10(3), e24756. https://doi.org/10.1016/j.heliyon.2024.e24756

  3. Ibrahim, A. M., Zaghamir, D. E. F., Sultan, H. M. S., Ibrahim, F. M., & Abdel-Aziz, H. R. (2024). Optimizing geriatric palliative care in Egypt: Comprehensive patient and family perspectives. Palliative & Supportive Care, 22(5), 1272–1281. https://doi.org/10.1017/S1478951524000216

  4. Ibrahim, F. M., Fadila, D. E., & Saad, M. T. (2022). A pilot protocol for improving institutionalized older adults’ psychosocial health during COVID-19 pandemic. International Journal of Health Sciences, 6(S4), 12521–12536. https://doi.org/10.53730/ijhs.v6nS4.12521

  5. Ibrahim, F. M., Salmi, R. N., Saif, M. A., & Mohammed, A. (2024). Sleep disorders’ prevalence and impact on academic performance among undergraduate nursing students in a selected university, United Arab Emirates. SAGE Open Nursing, 10, 23779608241274229. https://doi.org/10.1177/23779608241274229

Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479

Long Chang | Medicine and Health Sciences | Best Researcher Award

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.